Last reviewed · How we verify

NCT03352271: IIHD

Individualized Incremental Hemodialysis Study

Completed NA Last updated 13 January 2021
What this trial tests

NA trial testing Individualized Incremental hemodialysis in Hemodialysis Complication in 122 participants. Completed in 1 December 2020.

Timeline
1 June 2017
Primary endpoint
1 September 2020
1 December 2020

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment122
Start date1 June 2017
Primary completion1 September 2020
Estimated completion1 December 2020
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

18 and older, any sex, with Hemodialysis Complication or ESRD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thrice weekly hemodialysis has been the standard of care all-over the world for end-stage renal disease (ESRD) requiring renal replacement therapy (RRT). Despite being in the era of precision medicine and individualized healthcare, this program doesn't take into account patients with residual kidney function (RKF) who don't require a thrice weekly hemodialysis frequency. Incremental hemodialysis (defined as twice weekly hemodialysis initiation in incident hemodialysis patients with residual kidney function) has been raised as an alternative to the conventional thrice weekly dialysis. Retrospective trials has proved safety of a twice weekly initiation with comparative efficacy to the thrice weekly program. Despite that, there is paucity of prospective observational and rarity of randomized controlled trials comparing both regimens. In this study, the investigators tend to provide a more individualized incremental hemodialysis approach to incident hemodialysis patients with residual urine volume and RKF. The investigators will compare the results to ESRD patients initiating a thrice weekly hemodialysis program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Incremental versus standard dialysis for people with kidney failure
    Sabanayagam D, Hegerty K, Au E, Beruni N, et al · · 2023

Verify or expand the search:

Other recruiting trials for Hemodialysis Complication

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03352271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing